Skip to content

Immunodeficiency 79 C5543220

Published: July 22, 2026Updated: August 20, 2026

A rare genetic immunodeficiency causing increased susceptibility to infections. Treatment involves infection prevention and supportive immune therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent bacterial infections

!

Opportunistic fungal infection (oral candidiasis)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Failure to thrive

(immunologic)

Autoimmune cytopenias

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunoglobulin Replacement Therapy

Regular intravenous or subcutaneous immunoglobulin replacement to provide passive immunity and prevent recurrent infections in patients with primary immunodeficiency.

medication
3

Antibiotic Prophylaxis

Long-term prophylactic antibiotics to prevent bacterial infections, typically using trimethoprim-sulfamethoxazole or azithromycin as first-line agents.

medication

Additional treatment options

Infection Surveillance Protocol

Regular monitoring for signs of infection with prompt laboratory evaluation including complete blood counts, inflammatory markers, and cultures when indicated.

monitoring

Immunonutritional Support

Enhanced nutritional support with adequate protein, vitamins, and minerals to support immune function and prevent malnutrition-related immunodeficiency exacerbation.

dietary

Infection Prevention Measures

Implementation of rigorous hand hygiene, respiratory precautions, and avoidance of known infectious exposures to reduce infection risk in immunocompromised individuals.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Immunodeficiency 79 C5543220?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Immunodeficiency 79 C5543220. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy